A naïve CD4<sup>+</sup> T cell transfer colitis model was used to evaluate the suppressive function of iTregs in the presence or absence of CD8<sup>+</sup> T cells, while an autoimmune arthritis model was employed to assess therapeutic efficacy. The gene discussed is CD4; the disease is colitis.